Peizhi Lu
Impact in
-
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Ferroptosis and cancer prognosis
Papers in
-
- Histone Deacetylase Inhibitors Research 2
- RNA modifications and cancer 1
- Biochemical and Molecular Research 1
-
- Cancer, Lipids, and Metabolism 2
- Cancer, Hypoxia, and Metabolism 1
- Co-authors
- Guo‐Dong Lu (5 shared papers)Wenjing Su (3 shared papers)Yong Wu (4 shared papers)Jing Zhou (4 shared papers)Feng Ji (4 shared papers)Shing Chuan Hooi (4 shared papers)Tao Peng (4 shared papers)Guangzhi Zhu (3 shared papers)
In The Last Decade
Peizhi Lu
6 papers receiving 235 citations
Peers
Comparison fields: 5 of 43
- Cancer Research 117
- Pulmonary and Respiratory Medicine 118
- Genetics 18
- Hepatology 12
- Molecular Biology 109
Countries citing papers authored by Peizhi Lu
This map shows the geographic impact of Peizhi Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peizhi Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peizhi Lu more than expected).
Fields of papers citing papers by Peizhi Lu
This network shows the impact of papers produced by Peizhi Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peizhi Lu. The network helps show where Peizhi Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Peizhi Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 136 | |
| 2 | 2017 | 42 | |
| 3 | 2022 | 23 | |
| 4 | 2021 | 20 | |
| 5 | 2019 | 8 | |
| 6 | 2024 | 7 |
About Peizhi Lu
Peizhi Lu is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Epidemiology and Infectious Diseases, having authored 6 papers that have together received 236 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (2 papers), Cancer, Lipids, and Metabolism (2 papers), Cancer, Hypoxia, and Metabolism (1 paper), Ferroptosis and cancer prognosis (1 paper), RNA modifications and cancer (1 paper), Biochemical and Molecular Research (1 paper) and Autophagy in Disease and Therapy (1 paper). The work is most often cited by research in Cancer Research (117 citations), Pulmonary and Respiratory Medicine (118 citations), Genetics (18 citations), Hepatology (12 citations) and Molecular Biology (109 citations). Peizhi Lu has collaborated with scholars based in China, Singapore and Macao. Frequent co-authors include Guo‐Dong Lu, Wenjing Su, Yong Wu, Jing Zhou, Feng Ji, Shing Chuan Hooi, Tao Peng, Guangzhi Zhu, Hui-Qi Dai and Xiaowei Huang. Their work appears in journals such as Biochemical and Biophysical Research Communications, Experimental & Molecular Medicine, Frontiers in Oncology, Journal of Experimental & Clinical Cancer Research and Acta Pharmacologica Sinica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.